Invesco Ltd. Has $452,000 Stock Holdings in OrthoPediatrics Corp. $KIDS

Invesco Ltd. grew its position in OrthoPediatrics Corp. (NASDAQ:KIDS) by 12.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,349 shares of the company’s stock after purchasing an additional 1,986 shares during the period. Invesco Ltd. owned about 0.08% of OrthoPediatrics worth $452,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC raised its holdings in OrthoPediatrics by 4,618.2% in the first quarter. GAMMA Investing LLC now owns 10,616 shares of the company’s stock worth $261,000 after purchasing an additional 10,391 shares during the period. SG Americas Securities LLC raised its holdings in OrthoPediatrics by 175.0% in the first quarter. SG Americas Securities LLC now owns 20,039 shares of the company’s stock worth $494,000 after purchasing an additional 12,753 shares during the period. Dimensional Fund Advisors LP raised its holdings in OrthoPediatrics by 29.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after purchasing an additional 152,681 shares during the period. Deutsche Bank AG raised its holdings in OrthoPediatrics by 57.1% in the fourth quarter. Deutsche Bank AG now owns 14,393 shares of the company’s stock worth $334,000 after purchasing an additional 5,233 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in OrthoPediatrics by 76.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 19,863 shares of the company’s stock worth $460,000 after purchasing an additional 8,631 shares during the period. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Citigroup reissued a “market outperform” rating on shares of OrthoPediatrics in a research report on Friday, August 8th. Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. JMP Securities set a $35.00 price objective on shares of OrthoPediatrics and gave the stock a “market outperform” rating in a research report on Friday, August 8th. Finally, BTIG Research lowered their price objective on shares of OrthoPediatrics from $40.00 to $39.00 and set a “buy” rating for the company in a research report on Wednesday, August 6th. Seven investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, OrthoPediatrics currently has an average rating of “Moderate Buy” and a consensus target price of $34.14.

OrthoPediatrics Stock Up 1.0%

OrthoPediatrics stock opened at $20.91 on Friday. The company has a market cap of $524.21 million, a P/E ratio of -11.68 and a beta of 1.06. OrthoPediatrics Corp. has a 1-year low of $16.59 and a 1-year high of $33.14. The company has a fifty day simple moving average of $21.09 and a 200 day simple moving average of $22.00. The company has a current ratio of 6.66, a quick ratio of 3.43 and a debt-to-equity ratio of 0.27.

OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.17) by $0.06. The business had revenue of $61.08 million during the quarter, compared to the consensus estimate of $61.40 million. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. OrthoPediatrics has set its FY 2025 guidance at EPS. Research analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Fred Hite purchased 5,076 shares of the business’s stock in a transaction on Thursday, August 21st. The stock was purchased at an average price of $19.41 per share, for a total transaction of $98,525.16. Following the completion of the purchase, the chief financial officer directly owned 213,065 shares in the company, valued at $4,135,591.65. The trade was a 2.44% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 32.70% of the stock is currently owned by corporate insiders.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.